0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
TB Vaccines - Global Market Insights and Sales Trends 2024
Published Date: November 2023
|
Report Code: QYRE-Auto-9N9481
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global TB Vaccines Market Insights and Forecast to 2028
BUY CHAPTERS

TB Vaccines - Global Market Insights and Sales Trends 2024

Code: QYRE-Auto-9N9481
Report
November 2023
Pages:107
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

TB Vaccines - Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

TB Vaccines -  Market

TB Vaccines - Market

Tuberculosis (TB) vaccines are vaccinations intended for the prevention of tuberculosis. Immunotherapy as a defence against TB was first proposed in 1890 by Robert Koch. Today, the only effective tuberculosis vaccine in common use is bacilli Calmette-Guérin (BCG), first used in 1921.About three out of every 10,000 people who get the vaccine experience side effects, which are usually minor except in severely immuno-depressed individuals. While BCG immunization provides fairly effective protection for infants and young children, (including defence against TB meningitis and miliary TB), its efficacy in adults is variable, ranging from 0% to 80%.Several variables have been considered as responsible for the varying outcomes. Demand for TB immunotherapy advancement exists because the disease has become increasingly drug-resistant.
The global TB Vaccines market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of TB Vaccines in various end use industries. The expanding demands from the Hospitals, Private Clinics and Research Institutes,, are propelling TB Vaccines market. Immunotherapeutic Vaccines, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Booster Vaccines segment is estimated at % CAGR for the next seven-year period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Objectives

This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for TB Vaccines, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global TB Vaccines market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global TB Vaccines market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, TB Vaccines sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of TB Vaccines covered in this report include Merck & Co.,Inc, Sanofi Pasteur, Japan BCG Laboratory, China National Biotec Group, Serum Institute, India Pvt. Ltd, InterVax Ltd, GreenSignal and Bio Pharma Limited, etc.
The global TB Vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Merck & Co.,Inc
Sanofi Pasteur
Japan BCG Laboratory
China National Biotec Group
Serum Institute
India Pvt. Ltd
InterVax Ltd
GreenSignal
Bio Pharma Limited
Statens Serum Institut

Scope of TB Vaccines - Market Report

Report Metric Details
Report Name TB Vaccines - Market
CAGR 5%
Global TB Vaccines market, by region:
  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, UK, Italy, etc.)
  • Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
  • South America (Brazil, etc.)
  • Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global TB Vaccines market, Segment by Type:
  • Immunotherapeutic Vaccines
  • Booster Vaccines
  • Others
Global TB Vaccines market, by Application
  • Hospitals
  • Private Clinics
  • Research Institutes
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
  • Chapter Two: Detailed analysis of TB Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter Three: Sales, revenue of TB Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
  • Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
  • Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
  • Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter Twelve: Analysis of sales channel, distributors and customers.
  • Chapter Thirteen: Research Findings and Conclusion.

FAQ for this report

What are the Application segmentation covered in the TB Vaccines - Market report?

Ans: The Applications covered in the TB Vaccines - Market report are Hospitals, Private Clinics, Research Institutes

What are the Type segmentation covered in the TB Vaccines - Market report?

Ans: The Types covered in the TB Vaccines - Market report are Immunotherapeutic Vaccines, Booster Vaccines, Others

1 TB Vaccines Market Overview
1.1 TB Vaccines Product Overview
1.2 TB Vaccines Market Segment by Type
1.2.1 Immunotherapeutic Vaccines
1.2.2 Booster Vaccines
1.2.3 Others
1.3 Global TB Vaccines Market Size by Type
1.3.1 Global TB Vaccines Market Size Overview by Type (2018-2029)
1.3.2 Global TB Vaccines Historic Market Size Review by Type (2018-2023)
1.3.3 Global TB Vaccines Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America TB Vaccines Sales Breakdown by Type (2018-2023)
1.4.2 Europe TB Vaccines Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific TB Vaccines Sales Breakdown by Type (2018-2023)
1.4.4 Latin America TB Vaccines Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa TB Vaccines Sales Breakdown by Type (2018-2023)
2 Global TB Vaccines Market Competition by Company
2.1 Global Top Players by TB Vaccines Sales (2018-2023)
2.2 Global Top Players by TB Vaccines Revenue (2018-2023)
2.3 Global Top Players by TB Vaccines Price (2018-2023)
2.4 Global Top Manufacturers TB Vaccines Manufacturing Base Distribution, Sales Area, Product Type
2.5 TB Vaccines Market Competitive Situation and Trends
2.5.1 TB Vaccines Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by TB Vaccines Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in TB Vaccines as of 2022)
2.7 Date of Key Manufacturers Enter into TB Vaccines Market
2.8 Key Manufacturers TB Vaccines Product Offered
2.9 Mergers & Acquisitions, Expansion
3 TB Vaccines Status and Outlook by Region
3.1 Global TB Vaccines Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global TB Vaccines Historic Market Size by Region
3.2.1 Global TB Vaccines Sales in Volume by Region (2018-2023)
3.2.2 Global TB Vaccines Sales in Value by Region (2018-2023)
3.2.3 Global TB Vaccines Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global TB Vaccines Forecasted Market Size by Region
3.3.1 Global TB Vaccines Sales in Volume by Region (2024-2029)
3.3.2 Global TB Vaccines Sales in Value by Region (2024-2029)
3.3.3 Global TB Vaccines Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global TB Vaccines by Application
4.1 TB Vaccines Market Segment by Application
4.1.1 Hospitals
4.1.2 Private Clinics
4.1.3 Research Institutes
4.2 Global TB Vaccines Market Size by Application
4.2.1 Global TB Vaccines Market Size Overview by Application (2018-2029)
4.2.2 Global TB Vaccines Historic Market Size Review by Application (2018-2023)
4.2.3 Global TB Vaccines Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America TB Vaccines Sales Breakdown by Application (2018-2023)
4.3.2 Europe TB Vaccines Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific TB Vaccines Sales Breakdown by Application (2018-2023)
4.3.4 Latin America TB Vaccines Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa TB Vaccines Sales Breakdown by Application (2018-2023)
5 North America TB Vaccines by Country
5.1 North America TB Vaccines Historic Market Size by Country
5.1.1 North America TB Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America TB Vaccines Sales in Volume by Country (2018-2023)
5.1.3 North America TB Vaccines Sales in Value by Country (2018-2023)
5.2 North America TB Vaccines Forecasted Market Size by Country
5.2.1 North America TB Vaccines Sales in Volume by Country (2024-2029)
5.2.2 North America TB Vaccines Sales in Value by Country (2024-2029)
6 Europe TB Vaccines by Country
6.1 Europe TB Vaccines Historic Market Size by Country
6.1.1 Europe TB Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe TB Vaccines Sales in Volume by Country (2018-2023)
6.1.3 Europe TB Vaccines Sales in Value by Country (2018-2023)
6.2 Europe TB Vaccines Forecasted Market Size by Country
6.2.1 Europe TB Vaccines Sales in Volume by Country (2024-2029)
6.2.2 Europe TB Vaccines Sales in Value by Country (2024-2029)
7 Asia-Pacific TB Vaccines by Region
7.1 Asia-Pacific TB Vaccines Historic Market Size by Region
7.1.1 Asia-Pacific TB Vaccines Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific TB Vaccines Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific TB Vaccines Sales in Value by Region (2018-2023)
7.2 Asia-Pacific TB Vaccines Forecasted Market Size by Region
7.2.1 Asia-Pacific TB Vaccines Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific TB Vaccines Sales in Value by Region (2024-2029)
8 Latin America TB Vaccines by Country
8.1 Latin America TB Vaccines Historic Market Size by Country
8.1.1 Latin America TB Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America TB Vaccines Sales in Volume by Country (2018-2023)
8.1.3 Latin America TB Vaccines Sales in Value by Country (2018-2023)
8.2 Latin America TB Vaccines Forecasted Market Size by Country
8.2.1 Latin America TB Vaccines Sales in Volume by Country (2024-2029)
8.2.2 Latin America TB Vaccines Sales in Value by Country (2024-2029)
9 Middle East and Africa TB Vaccines by Country
9.1 Middle East and Africa TB Vaccines Historic Market Size by Country
9.1.1 Middle East and Africa TB Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa TB Vaccines Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa TB Vaccines Sales in Value by Country (2018-2023)
9.2 Middle East and Africa TB Vaccines Forecasted Market Size by Country
9.2.1 Middle East and Africa TB Vaccines Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa TB Vaccines Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Merck & Co.,Inc
10.1.1 Merck & Co.,Inc Company Information
10.1.2 Merck & Co.,Inc Introduction and Business Overview
10.1.3 Merck & Co.,Inc TB Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Merck & Co.,Inc TB Vaccines Products Offered
10.1.5 Merck & Co.,Inc Recent Development
10.2 Sanofi Pasteur
10.2.1 Sanofi Pasteur Company Information
10.2.2 Sanofi Pasteur Introduction and Business Overview
10.2.3 Sanofi Pasteur TB Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Sanofi Pasteur TB Vaccines Products Offered
10.2.5 Sanofi Pasteur Recent Development
10.3 Japan BCG Laboratory
10.3.1 Japan BCG Laboratory Company Information
10.3.2 Japan BCG Laboratory Introduction and Business Overview
10.3.3 Japan BCG Laboratory TB Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Japan BCG Laboratory TB Vaccines Products Offered
10.3.5 Japan BCG Laboratory Recent Development
10.4 China National Biotec Group
10.4.1 China National Biotec Group Company Information
10.4.2 China National Biotec Group Introduction and Business Overview
10.4.3 China National Biotec Group TB Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.4.4 China National Biotec Group TB Vaccines Products Offered
10.4.5 China National Biotec Group Recent Development
10.5 Serum Institute
10.5.1 Serum Institute Company Information
10.5.2 Serum Institute Introduction and Business Overview
10.5.3 Serum Institute TB Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Serum Institute TB Vaccines Products Offered
10.5.5 Serum Institute Recent Development
10.6 India Pvt. Ltd
10.6.1 India Pvt. Ltd Company Information
10.6.2 India Pvt. Ltd Introduction and Business Overview
10.6.3 India Pvt. Ltd TB Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.6.4 India Pvt. Ltd TB Vaccines Products Offered
10.6.5 India Pvt. Ltd Recent Development
10.7 InterVax Ltd
10.7.1 InterVax Ltd Company Information
10.7.2 InterVax Ltd Introduction and Business Overview
10.7.3 InterVax Ltd TB Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.7.4 InterVax Ltd TB Vaccines Products Offered
10.7.5 InterVax Ltd Recent Development
10.8 GreenSignal
10.8.1 GreenSignal Company Information
10.8.2 GreenSignal Introduction and Business Overview
10.8.3 GreenSignal TB Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.8.4 GreenSignal TB Vaccines Products Offered
10.8.5 GreenSignal Recent Development
10.9 Bio Pharma Limited
10.9.1 Bio Pharma Limited Company Information
10.9.2 Bio Pharma Limited Introduction and Business Overview
10.9.3 Bio Pharma Limited TB Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Bio Pharma Limited TB Vaccines Products Offered
10.9.5 Bio Pharma Limited Recent Development
10.10 Statens Serum Institut
10.10.1 Statens Serum Institut Company Information
10.10.2 Statens Serum Institut Introduction and Business Overview
10.10.3 Statens Serum Institut TB Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Statens Serum Institut TB Vaccines Products Offered
10.10.5 Statens Serum Institut Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 TB Vaccines Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 TB Vaccines Industrial Chain Analysis
11.4 TB Vaccines Market Dynamics
11.4.1 TB Vaccines Industry Trends
11.4.2 TB Vaccines Market Drivers
11.4.3 TB Vaccines Market Challenges
11.4.4 TB Vaccines Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 TB Vaccines Distributors
12.3 TB Vaccines Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of Tables
    Table 1. Major Company of Immunotherapeutic Vaccines
    Table 2. Major Company of Booster Vaccines
    Table 3. Major Company of Others
    Table 4. Global TB Vaccines Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
    Table 5. Global TB Vaccines Sales by Type (2018-2023) & (K Units)
    Table 6. Global TB Vaccines Sales Market Share in Volume by Type (2018-2023)
    Table 7. Global TB Vaccines Sales by Type (2018-2023) & (US& Million)
    Table 8. Global TB Vaccines Market Share in Value by Type (2018-2023)
    Table 9. Global TB Vaccines Price by Type (2018-2023) & (USD/Unit)
    Table 10. Global TB Vaccines Sales by Type (2024-2029) & (K Units)
    Table 11. Global TB Vaccines Sales Market Share in Volume by Type (2024-2029)
    Table 12. Global TB Vaccines Sales by Type (2024-2029) & (US$ Million)
    Table 13. Global TB Vaccines Sales Market Share in Value by Type (2024-2029)
    Table 14. Global TB Vaccines Price by Type (2024-2029) & (USD/Unit)
    Table 15. North America TB Vaccines Sales by Type (2018-2023) & (K Units)
    Table 16. North America TB Vaccines Sales by Type (2018-2023) & (US$ Million)
    Table 17. Europe TB Vaccines Sales (K Units) by Type (2018-2023)
    Table 18. Europe TB Vaccines Sales by Type (2018-2023) & (US$ Million)
    Table 19. Asia-Pacific TB Vaccines Sales (K Units) by Type (2018-2023)
    Table 20. Asia-Pacific TB Vaccines Sales by Type (2018-2023) & (US$ Million)
    Table 21. Latin America TB Vaccines Sales (K Units) by Type (2018-2023)
    Table 22. Latin America TB Vaccines Sales by Type (2018-2023) & (US$ Million)
    Table 23. Middle East and Africa TB Vaccines Sales (K Units) by Type (2018-2023)
    Table 24. Middle East and Africa TB Vaccines Sales by Type (2018-2023) & (US$ Million)
    Table 25. Global TB Vaccines Sales by Company (2018-2023) & (K Units)
    Table 26. Global TB Vaccines Sales Share by Company (2018-2023)
    Table 27. Global TB Vaccines Revenue by Company (2018-2023) & (US$ Million)
    Table 28. Global TB Vaccines Revenue Share by Company (2018-2023)
    Table 29. Global Market TB Vaccines Price by Company (2018-2023) & (USD/Unit)
    Table 30. Global TB Vaccines Top Manufacturers Manufacturing Base Distribution and Sales Area
    Table 31. Global TB Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in TB Vaccines as of 2022)
    Table 33. Date of Key Manufacturers Enter into TB Vaccines Market
    Table 34. Key Manufacturers TB Vaccines Product Type
    Table 35. Mergers & Acquisitions, Expansion Plans
    Table 36. Global TB Vaccines Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 37. Global TB Vaccines Sales by Region (2018-2023) & (K Units)
    Table 38. Global TB Vaccines Sales Market Share in Volume by Region (2018-2023)
    Table 39. Global TB Vaccines Sales by Region (2018-2023) & (US$ Million)
    Table 40. Global TB Vaccines Sales Market Share in Value by Region (2018-2023)
    Table 41. Global TB Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 42. Global TB Vaccines Sales by Region (2024-2029) & (K Units)
    Table 43. Global TB Vaccines Sales Market Share in Volume by Region (2024-2029)
    Table 44. Global TB Vaccines Sales by Region (2024-2029) & (US$ Million)
    Table 45. Global TB Vaccines Sales Market Share in Value by Region (2024-2029)
    Table 46. Global TB Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2029)
    Table 47. Global TB Vaccines Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
    Table 48. Global TB Vaccines Sales by Application (2018-2023) & (K Units)
    Table 49. Global TB Vaccines Sales Market Share in Volume by Application (2018-2023)
    Table 50. Global TB Vaccines Sales by Application (2018-2023) & (US$ Million)
    Table 51. Global TB Vaccines Sales Market Share in Value by Application (2018-2023)
    Table 52. Global TB Vaccines Price by Application (2018-2023) & (USD/Unit)
    Table 53. Global TB Vaccines Sales by Application (2024-2029) & (K Units)
    Table 54. Global TB Vaccines Sales Market Share in Volume by Application (2024-2029)
    Table 55. Global TB Vaccines Sales by Application (2024-2029) & (US$ Million)
    Table 56. Global TB Vaccines Sales Market Share in Value by Application (2024-2029)
    Table 57. Global TB Vaccines Price by Application (2024-2029) & (USD/Unit)
    Table 58. North America TB Vaccines Sales by Application (2018-2023) (K Units)
    Table 59. North America TB Vaccines Sales by Application (2018-2023) & (US$ Million)
    Table 60. Europe TB Vaccines Sales by Application (2018-2023) (K Units)
    Table 61. Europe TB Vaccines Sales by Application (2018-2023) & (US$ Million)
    Table 62. Asia-Pacific TB Vaccines Sales by Application (2018-2023) (K Units)
    Table 63. Asia-Pacific TB Vaccines Sales by Application (2018-2023) & (US$ Million)
    Table 64. Latin America TB Vaccines Sales by Application (2018-2023) (K Units)
    Table 65. Latin America TB Vaccines Sales by Application (2018-2023) & (US$ Million)
    Table 66. Middle East and Africa TB Vaccines Sales by Application (2018-2023) (K Units)
    Table 67. Middle East and Africa TB Vaccines Sales by Application (2018-2023) & (US$ Million)
    Table 68. North America TB Vaccines Sales by Country (2018-2023) & (K Units)
    Table 69. North America TB Vaccines Sales Market Share in Volume by Country (2018-2023)
    Table 70. North America TB Vaccines Sales by Country (2018-2023) & (US$ Million)
    Table 71. North America TB Vaccines Sales Market Share in Value by Country (2018-2023)
    Table 72. North America TB Vaccines Sales by Country (2024-2029) & (K Units)
    Table 73. North America TB Vaccines Sales Market Share in Volume by Country (2024-2029)
    Table 74. North America TB Vaccines Sales by Country (2024-2029) & (US$ Million)
    Table 75. North America TB Vaccines Sales Market Share in Value by Country (2024-2029)
    Table 76. Europe TB Vaccines Sales by Country (2018-2023) & (K Units)
    Table 77. Europe TB Vaccines Sales Market Share in Volume by Country (2018-2023)
    Table 78. Europe TB Vaccines Sales by Country (2018-2023) & (US$ Million)
    Table 79. Europe TB Vaccines Sales Market Share in Value by Country (2018-2023)
    Table 80. Europe TB Vaccines Sales by Country (2024-2029) & (K Units)
    Table 81. Europe TB Vaccines Sales Market Share in Volume by Country (2024-2029)
    Table 82. Europe TB Vaccines Sales by Country (2024-2029) & (US$ Million)
    Table 83. Europe TB Vaccines Sales Market Share in Value by Country (2024-2029)
    Table 84. Asia-Pacific TB Vaccines Sales by Region (2018-2023) & (K Units)
    Table 85. Asia-Pacific TB Vaccines Sales Market Share in Volume by Region (2018-2023)
    Table 86. Asia-Pacific TB Vaccines Sales by Region (2018-2023) & (US$ Million)
    Table 87. Asia-Pacific TB Vaccines Sales Market Share in Value by Region (2018-2023)
    Table 88. Asia-Pacific TB Vaccines Sales by Region (2024-2029) & (K Units)
    Table 89. Asia-Pacific TB Vaccines Sales Market Share in Volume by Region (2024-2029)
    Table 90. Asia-Pacific TB Vaccines Sales by Region (2024-2029) & (US$ Million)
    Table 91. Asia-Pacific TB Vaccines Sales Market Share in Value by Region (2024-2029)
    Table 92. Latin America TB Vaccines Sales by Country (2018-2023) & (K Units)
    Table 93. Latin America TB Vaccines Sales Market Share in Volume by Country (2018-2023)
    Table 94. Latin America TB Vaccines Sales by Country (2018-2023) & (US$ Million)
    Table 95. Latin America TB Vaccines Sales Market Share in Value by Country (2018-2023)
    Table 96. Latin America TB Vaccines Sales by Country (2024-2029) & (K Units)
    Table 97. Latin America TB Vaccines Sales Market Share in Volume by Country (2024-2029)
    Table 98. Latin America TB Vaccines Sales by Country (2024-2029) & (US$ Million)
    Table 99. Latin America TB Vaccines Sales Market Share in Value by Country (2024-2029)
    Table 100. Middle East and Africa TB Vaccines Sales by Country (2018-2023) & (K Units)
    Table 101. Middle East and Africa TB Vaccines Sales Market Share in Volume by Country (2018-2023)
    Table 102. Middle East and Africa TB Vaccines Sales by Country (2018-2023) & (US$ Million)
    Table 103. Middle East and Africa TB Vaccines Sales Market Share in Value by Country (2018-2023)
    Table 104. Middle East and Africa TB Vaccines Sales by Country (2024-2029) & (K Units)
    Table 105. Middle East and Africa TB Vaccines Sales Market Share in Volume by Country (2024-2029)
    Table 106. Middle East and Africa TB Vaccines Sales by Country (2024-2029) & (US$ Million)
    Table 107. Middle East and Africa TB Vaccines Sales Market Share in Value by Country (2024-2029)
    Table 108. Merck & Co.,Inc Company Information
    Table 109. Merck & Co.,Inc Introduction and Business Overview
    Table 110. Merck & Co.,Inc TB Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 111. Merck & Co.,Inc TB Vaccines Product
    Table 112. Merck & Co.,Inc Recent Development
    Table 113. Sanofi Pasteur Company Information
    Table 114. Sanofi Pasteur Introduction and Business Overview
    Table 115. Sanofi Pasteur TB Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 116. Sanofi Pasteur TB Vaccines Product
    Table 117. Sanofi Pasteur Recent Development
    Table 118. Japan BCG Laboratory Company Information
    Table 119. Japan BCG Laboratory Introduction and Business Overview
    Table 120. Japan BCG Laboratory TB Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 121. Japan BCG Laboratory TB Vaccines Product
    Table 122. Japan BCG Laboratory Recent Development
    Table 123. China National Biotec Group Company Information
    Table 124. China National Biotec Group Introduction and Business Overview
    Table 125. China National Biotec Group TB Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 126. China National Biotec Group TB Vaccines Product
    Table 127. China National Biotec Group Recent Development
    Table 128. Serum Institute Company Information
    Table 129. Serum Institute Introduction and Business Overview
    Table 130. Serum Institute TB Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 131. Serum Institute TB Vaccines Product
    Table 132. Serum Institute Recent Development
    Table 133. India Pvt. Ltd Company Information
    Table 134. India Pvt. Ltd Introduction and Business Overview
    Table 135. India Pvt. Ltd TB Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 136. India Pvt. Ltd TB Vaccines Product
    Table 137. India Pvt. Ltd Recent Development
    Table 138. InterVax Ltd Company Information
    Table 139. InterVax Ltd Introduction and Business Overview
    Table 140. InterVax Ltd TB Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 141. InterVax Ltd TB Vaccines Product
    Table 142. InterVax Ltd Recent Development
    Table 143. GreenSignal Company Information
    Table 144. GreenSignal Introduction and Business Overview
    Table 145. GreenSignal TB Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 146. GreenSignal TB Vaccines Product
    Table 147. GreenSignal Recent Development
    Table 148. Bio Pharma Limited Company Information
    Table 149. Bio Pharma Limited Introduction and Business Overview
    Table 150. Bio Pharma Limited TB Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 151. Bio Pharma Limited TB Vaccines Product
    Table 152. Bio Pharma Limited Recent Development
    Table 153. Statens Serum Institut Company Information
    Table 154. Statens Serum Institut Introduction and Business Overview
    Table 155. Statens Serum Institut TB Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 156. Statens Serum Institut TB Vaccines Product
    Table 157. Statens Serum Institut Recent Development
    Table 158. Key Raw Materials Lists
    Table 159. Raw Materials Key Suppliers Lists
    Table 160. TB Vaccines Market Trends
    Table 161. TB Vaccines Market Drivers
    Table 162. TB Vaccines Market Challenges
    Table 163. TB Vaccines Market Restraints
    Table 164. TB Vaccines Distributors List
    Table 165. TB Vaccines Downstream Customers
    Table 166. Research Programs/Design for This Report
    Table 167. Key Data Information from Secondary Sources
    Table 168. Key Data Information from Primary Sources
List of Figures
    Figure 1. TB Vaccines Product Picture
    Figure 2. Global TB Vaccines Market Size, 2018 VS 2022 VS 2029 (US$ Million)
    Figure 3. Global TB Vaccines Market Size Status and Outlook (2018-2029) & (US$ Million)
    Figure 4. Global TB Vaccines Sales Status and Outlook (2018-2029) & (K Units)
    Figure 5. Product Picture of Immunotherapeutic Vaccines
    Figure 6. Global Immunotherapeutic Vaccines Sales YoY Growth (2018-2029) & (K Units)
    Figure 7. Product Picture of Booster Vaccines
    Figure 8. Global Booster Vaccines Sales YoY Growth (2018-2029) & (K Units)
    Figure 9. Product Picture of Others
    Figure 10. Global Others Sales YoY Growth (2018-2029) & (K Units)
    Figure 11. Global TB Vaccines Sales by Type (2018-2029) & (US$ Million)
    Figure 12. Global TB Vaccines Sales Market Share by Type in 2022 & 2029
    Figure 13. North America TB Vaccines Sales Market Share in Volume by Type in 2022
    Figure 14. North America TB Vaccines Sales Market Share in Value by Type in 2022
    Figure 15. Europe TB Vaccines Sales Market Share in Volume by Type in 2022
    Figure 16. Europe TB Vaccines Sales Market Share in Value by Type in 2022
    Figure 17. Asia-Pacific TB Vaccines Sales Market Share in Volume by Type in 2022
    Figure 18. Asia-Pacific TB Vaccines Sales Market Share in Value by Type in 2022
    Figure 19. Latin America TB Vaccines Sales Market Share in Volume by Type in 2022
    Figure 20. Latin America TB Vaccines Sales Market Share in Value by Type in 2022
    Figure 21. Middle East and Africa TB Vaccines Sales Market Share in Volume by Type in 2022
    Figure 22. Middle East and Africa TB Vaccines Sales Market Share in Value by Type in 2022
    Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by TB Vaccines Sales in 2022
    Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by TB Vaccines Revenue in 2022
    Figure 25. TB Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
    Figure 26. Product Picture of Hospitals
    Figure 27. Global Hospitals Sales YoY Growth (2018-2029) & (K Units)
    Figure 28. Product Picture of Private Clinics
    Figure 29. Global Private Clinics Sales YoY Growth (2018-2029) & (K Units)
    Figure 30. Product Picture of Research Institutes
    Figure 31. Global Research Institutes Sales YoY Growth (2018-2029) & (K Units)
    Figure 32. Global TB Vaccines Sales by Application (2018-2029) & (US$ Million)
    Figure 33. Global TB Vaccines Sales Market Share by Application in 2022 & 2029
    Figure 34. North America TB Vaccines Sales Market Share in Volume by Application in 2022
    Figure 35. North America TB Vaccines Sales Market Share in Value by Application in 2022
    Figure 36. Europe TB Vaccines Sales Market Share in Volume by Application in 2022
    Figure 37. Europe TB Vaccines Sales Market Share in Value by Application in 2022
    Figure 38. Asia-Pacific TB Vaccines Sales Market Share in Volume by Application in 2022
    Figure 39. Asia-Pacific TB Vaccines Sales Market Share in Value by Application in 2022
    Figure 40. Latin America TB Vaccines Sales Market Share in Volume by Application in 2022
    Figure 41. Latin America TB Vaccines Sales Market Share in Value by Application in 2022
    Figure 42. Middle East and Africa TB Vaccines Sales Market Share in Value by Application in 2022
    Figure 43. Key Raw Materials Price
    Figure 44. TB Vaccines Manufacturing Cost Structure
    Figure 45. TB Vaccines Industrial Chain Analysis
    Figure 46. Channels of Distribution
    Figure 47. Distributors Profiles
    Figure 48. Bottom-up and Top-down Approaches for This Report
    Figure 49. Data Triangulation
    Figure 50. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3350

This license allows only one user to access the PDF.
Electronic (PDF)

$5025

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$6700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure

SIMILAR REPORTS